ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Breast Cancer Working Group Lists Research Needed

July 1, 1988

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

In Brief: Oncology Nursing Society Names Board Of Directors

May 16, 2014